| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |